Solvay SA

AGM Information • May 9, 2017

MINUTES OF THE ORDINARY ANNUAL SOLVAY S.A. SHAREHOLDERS' MEETING On Tuesday, May 9, 2017 at 10:30 a.m.

The shareholders of the company Solvay S.A. with its corporate offices in Brussels, rue de Ransbeek, no. 310, gathered for their Ordinary annual meeting on Tuesday, May 9, 2017, at the Square, Meeting Center Brussels, Mont des Arts, 1000 Brussels.

The session was opened at 10:30 a.m.

During his speech, Mr. Nicolas Boël indicated that concerns about world geopolitical problems currently override the economic factors or enterprise risks.

The Group's transformation to a specialty chemicals company continued in 2016. Thus the Group was able to finalize the process of divesting of PVC activities in Europe, in Thailand and in South America and also announced the sale of its acetate cable activity. Each time, the Group's focus was to prioritize a solution to ensure the future of these businesses.

The dynamic of a quest for new market segments for new products and innovative solutions continues. It is also evidenced by Solvay's engagement on different fronts: commitment to closer market proximity and delegation of responsibility in the field, commitment to our customers to develop quality and innovative materials and formulations, societal commitment and finally social commitment through a global approach for protection of our employees (Solvay Cares).

N. Boël then reviewed aspects of governance, in particular the composition of the Board (renewal of terms and nomination of Mrs. Lemarchand as a board member), the dividend policy and proposed distribution for 2016. Finally, the evolution of the stock price was discussed.

In accordance with article 39 of the by-laws, the General Committee was composed.

The Chairman designated Mr. Michel Defourny, Group Corporate Secretary of the company, as Secretary.

Of the shareholders in attendance Mrs. Savina de Limon Triest and Mr. Gaëtan Vercruysse agreed to act as tellers.

The members of the Board of Directors in attendance completed the General Committee.

The Chairman noted that:

• the notifications complete with the agenda were published in the "Moniteur belge," "L'Echo" and "De Tijd" of April 7, 2017, with a specimen copy of each of these publications made available to the tellers;

• the registered shareholders were also notified by letter on April 7, 2017, as were the Directors and the External Auditors on the same date; the model letter is also made available to the tellers.

According to the attendance list signed by all present at the meeting, both in their own name as well as proxyholders, the shareholders present or represented owned a collective total at the start of the meeting of 62.023.754 shares of the 105.876.416 that make up the registered capital, or 58,58 %.

The Chairman declared the meeting properly constituted.

The shareholders then went on to examine the agenda point by point.

1. The Board of Directors had drawn up a management report on operations for the fiscal year 2016 – including a Declaration of Corporate Governance –, in which may be found all information required by law. The Board took note of the report of the External Auditor and made no particular remarks on its contents. The Chairman noted that the necessary measures had been taken to meet legal obligations in terms of distribution of the management reports concerning the operations of the fiscal year 2016, including the Declaration of Corporate Governance, and the report of the Auditor.

In light of these circumstances, the meeting opted not to have the management report on the operations of 2016 read.

Mr. Jean-Pierre Clamadieu began his presentation by recalling the Group's ambition to become a multi-specialty chemical company and supplier of solutions. 2016 constituted, in this regard, a new step in the Group's transformation with the finalization of divestiture of the PVC activities, the Acetow activity and the Form resins as well as the Cross-linkable compounds.

He then presented the positions of world leader occupied by the Group in its four clusters and the evolution of the Group's profile to that of a player with a more diversified portfolio both in terms of geography and market presence. Value creation today is focused on the response to challenges facing our customers, through the expertise and technological leadership held by the Group. He then illustrated the Solvay Dental 360 application in Medical devices, as well as the Group's strategy in workplace safety, acquisition and motivation of talent and diversity. This latter is demonstrated by the renewal of the IndustryAll Global Union agreement and the 2017 Solvay Cares program.

J.-P Clamadieu reviewed the 2016 accomplishments in innovation (2350 people in R&I, 350 MEUR in research), sustainability and financial performance (sales of 10.9 GEUR, EBITDA of 2.3 GEUR, Free cash flow of 876 MEUR), as well as the results of the first quarter of 2017.

He concluded by presenting the financial prospects for 2017.

The supporting documents for the speeches by Messrs. Nicolas Boël and Clamadieu will be attached to the minutes. They will also be distributed on the Internet.

In view of the wide distribution of the Auditor's report, reading of it was dispensed with.

In conformity with regulatory provisions, the annual financial statements, the management report, the Declaration of Corporate Governance, the report of the Auditor, as well as the Compensation Report were submitted to the Works Council of Solvay SA at Brussels. The reading of the Works Council Report was dispensed with. For those who desire to know what is in this report, a copy is available for them from the tellers.

• 1. The Meeting approved the Compensation Report found in chapter 6 of the Declaration of Corporate Governance, with a majority of 81,42 % of votes.
• 1. The Chairman indicated that the FSMA (Financial Services and Market Authority) recommends that listed companies include in the agenda a point concerning consolidated accounts for which there is no shareholders' vote.

The consolidated financial statements for the year 2016 were verified and approved by the Board of Directors. The Board took notice of the report of the Auditor and made no special remarks on the subject.

The Chairman then gave the floor to shareholders to make comments or request information.

Once replies were given to these questions and observations, he declared the discussion closed and invited the shareholders to pass to the review of the other resolutions to be taken.

1. The Meeting approved the annual accounts of Solvay S.A. as well as the proposal for allocation of the profits by a majority of 99,48 % of the votes.

Each fully paid share will receive a gross dividend per share of 3.45 EUR. Taking into account the interim payment of 1.32 EUR gross, paid on January 18, 2017, the balance of the dividend will amount to 2.13 EUR gross, payable as of May 16, 2017.

1. By a majority of 98,94 % of the votes, the shareholders granted to the Directors in office for 2016 a discharge for the performance of their duties during that year.

By a majority of 98,94 % of the votes, the shareholders granted to the External Auditor in office for 2016 a discharge for the performance of its duties during that year.

• 6a) The Meeting proceeded to re-elect, for a term of four years, Mr. Nicolas Boël, Jean-Pierre Clamadieu, Bernard de Laguiche, Hervé Coppens d'Eeckenbrugge and Mrs. Evelyn du Monceau, Françoise de Viron and Amparo Moraleda whose terms expire at the end of this meeting.
• 6b) Mr. Nicolas Boël was re-elected as Director, with a majority of 90,07 % of the votes.

Mr. Jean-Pierre Clamadieu was re-elected as Director, with a majority of 99,48 % of the votes.

Mr. Bernard de Laguiche was re-elected as Director, with a majority of 97,76 % of the votes.

Mr. Hervé Coppens d'Eeckenbrugge was re-elected as Director, with a majority of 99,66 % of the votes.

Mrs. Evelyn du Monceau was re-elected as Director, with a majority of 99,60 % of the votes.

Mrs. Françoise de Viron was re-elected as Director, with a majority of 99,66 % of the votes.

Mrs. Amparo Moraleda was re-elected as Director, with a majority of 99,21% of the votes.

Their terms will expire at the end of the general shareholders' meeting in May 2021.

6c) It was proposed to confirm the nomination of Mr. Hervé Coppens d'Eeckenbrugge as independent Director on the Board of Directors. Mr. Hervé Coppens d'Eeckenbrugge was confirmed as independent Director with a majority of 99,89 % of the votes.

It was proposed to confirm the nomination of Mrs. Evelyn du Monceau as independent Director on the Board of Directors. Mrs. Evelyn du Monceau was confirmed as independent Director with a majority of 99,71 % of the votes.

It was proposed to confirm the nomination of Mrs. Françoise de Viron as independent Director on the Board of Directors. Mrs. Françoise de Viron was confirmed as independent Director with a majority of 100 % of the votes.

It was proposed to confirm the nomination of Mrs. Amparo Moraleda as independent Director on the Board of Directors.

Mrs. Amparo Moraleda was confirmed as independent Director with a majority of 100 % of the votes.

Information regarding the proposal for re-election of Mr. Hervé Coppens d'Eeckenbrugge and Mrs Evelyn du Monceau,Françoise de Viron and Amparo Moraleda as independent Directors was provided to the Works Council on March 13, 2017.

6d) It was proposed to designate Mrs. Agnès Lemarchand as a Director for a four-year term. Mrs. Agnès Lemarchand was elected as Director for a term of four years with a majority of 99,56 % of the votes.

Her term will expire at the end of the general shareholders' meeting in May 2021.

• 6e) Mrs. Agnès Lemarchand was designated as independent Director with a majority of 99,99 % of the votes. The information regarding the proposal of her designation as independent Director was provided to the Works Council on March 13, 2017.
• 1. Miscellaneous. Nothing to report.

The agenda having been completed, the Chairman adjourned the meeting at 12.15 pm.

Aantal uitgegeven aandelen Nombre d'actions émises	105,876,416
Aantal vertegenwoordigde aandelen Nombre d'actions représentées	62,023,754
Vertegenwoordigd kapitaal Capital représenté	58.58%

$2.$ Approbation du rapport de rémunération Goedkeuring van het remuneratieverslag Approval of compensation report

	Pour/Voor/For	50.472.327
	Contre/Tegen/Against	11.515.173
	Abstention/Onthouding/Abstain	36.254
	% Pour/Voor/For	81,42%
	Total des votes/Totaal aantal stemmen/Total Votes	62.023.754
	Approbation des comptes annuels 2016 - Affectation du bénéfice et fixation du dividende
	Goedkeuring van de jaarrekeningen 2016 - Winstverdeling en vaststelling van het dividend

vaststelling van het dividend
Approval of annual accounts from 2016 - Distribution of earnings and setting of dividend
Pour/Voor/For	61.668.110
Contre/Tegen/Against	325.239
Abstention/Onthouding/Abstain	30.405
% Pour/Voor/For	99,48%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754

5.a.	Décharge aux Administrateurs pour les opérations de l'exercice 2016
	Kwijting aan de Bestuurders voor de verrichtingen van het boekjaar 2016
	Discharge of liability to the Board members for the operations for the year 2016
	Pour/Voor/For	61.215.189
	Contre/Tegen/Against	653.624
	Abstention/Onthouding/Abstain	154.941
	% Pour/Voor/For	98,94%
	Total des votes/Totaal aantal stemmen/Total Votes	62.023.754
5.b.	Décharge au Commissaire pour les opérations de l'exercice 2016
	Kwijting aan de Commissaris voor de verrichtingen van het boekjaar 2016
	Discharge of liability to the External Auditor for the operations for the year 2016
	Pour/Voor/For	61.053.434
	Contre/Tegen/Against	654.239
	Abstention/Onthouding/Abstain	316.081
	% Pour/Voor/For	98,94%
	Total des votes/Totaal aantal stemmen/Total Votes	62.023.754

6.b.1. Renouvellement du mandat de M. Nicolas Boël Vernieuwing van het mandaat van Dhr. Nicolas Boël

Term renewal for Mr. Nicolas Boël

Pour/Voor/For 55.738.396 Contre/Tegen/Against 6.148.147 137.211 Abstention/Onthouding/Abstain % Pour/Voor/For 90,07% Total des votes/Totaal aantal stemmen/Total Votes 62.023.754 SOLVAY

6.b.2. Renouvellement du mandat de M. Jean-Pierre Clamadieu Vernieuwing van het mandaat van Dhr. Jean-Pierre Clamadieu Term renewal for Mr. Jean-Pierre Clamadieu

Pour/Voor/For	61.183.885
Contre/Tegen/Against	320.900
Abstention/Onthouding/Abstain	518.969
% Pour/Voor/For	99,48%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754

6.b.3. Renouvellement du mandat de M. Bernard de Laguiche

Vernieuwing van het mandaat van Dhr. Bernard de Laguiche

Term renewal for Mr. Bernard de Laguiche

Pour/Voor/For	60.202.712
Contre/Tegen/Against	1.380.515
Abstention/Onthouding/Abstain	440.527
% Pour/Voor/For	97,76%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754
6.b.4. Renouvellement du mandat de M. Hervé Coppens d'Eeckenbrugge
Vernieuwing van het mandaat van Dhr. Hervé Coppens d'Eeckenbrugge
Term renewal for Mr. Hervé Coppens d'Eeckenbrugge
Pour/Voor/For	61.656.657
Contre/Tegen/Against	209.236
Abstention/Onthouding/Abstain	157.861
% Pour/Voor/For	99,66%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754
	SOLVAY

6.b.5. Renouvellement du mandat de Mme Evelyn du Monceau Vernieuwing van het mandaat van Mevr. Evelyn du Monceau Term renewal for Mrs. Evelyn du Monceau

Pour/Voor/For	61.557.118
Contre/Tegen/Against	247.427
Abstention/Onthouding/Abstain	219.209
% Pour/Voor/For	99,60%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754

6.b.6. Renouvellement du mandat de Mme Françoise de Viron Vernieuwing van het mandaat van Mevr. Françoise de Viron Term renewal for Mrs. Françoise de Viron

Pour/Voor/For	61.570.579
Contre/Tegen/Against	207.558
Abstention/Onthouding/Abstain	245.617
% Pour/Voor/For	99,66%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754

6.b.7. Renouvellement du mandat de Mme Amparo Moraleda Vernieuwing van het mandaat van Mevr. Amparo Moraleda

Term renewal for Mrs. Amparo Moraleda

Pour/Voor/For	61.263.659
Contre/Tegen/Against	490.787
Abstention/Onthouding/Abstain	269.308
% Pour/Voor/For	99,21%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754
6.c.1. Confirmation de M. Hervé Coppens d'Eeckenbrugge comme administrateur indépendant
Bevestiging van Dhr. Hervé Coppens d'Eeckenbrugge als onafhankelijk bestuurder
Confirmation of Mr. Hervé Coppens d'Eeckenbrugge as independent Board member
Pour/Voor/For	61.770.450
Contre/Tegen/Against	65.110
Abstention/Onthouding/Abstain	188.194
% Pour/Voor/For	99,89%
Total des votes/Totaal aantal stemmen/Total Votes	62.023.754
	SOLVAY

6.c.2. Confirmation de Mme Evelyn du Monceau
Bevestiging van Mevr. Evelyn du Monceau
Confirmation of Mrs Evelyn du Monceau
61.562.092
180.450
281.212
99,71%
Total des votes/Totaal aantal stemmen/Total Votes 62.023.754
SOLVAY
6.c.3. Confirmation de Mme Françoise de Viron Bevestiging van Mevr. Françoise de Viron
61.918.997
1.251
103.506
100,00%
Total des votes/Totaal aantal stemmen/Total Votes 62.023.754

	6.c.4. Confirmation de Mme Amparo Moraleda comme administrateur indépendant
	Bevestiging van Mevr. Amparo Moraleda als onafhankelijk bestuurder
	Confirmation of Mrs Amparo Moraleda as independent Board member
	Pour/Voor/For	61.914.836
	Contre/Tegen/Against	2.071
	Abstention/Onthouding/Abstain	106.847
	% Pour/Voor/For	100,00%
		62.023.754
	Total des votes/Totaal aantal stemmen/Total Votes
		SOLVAY
	Nomination comme administrateur de Mme Agnès Lemarchand Benoeming als bestuurder van Mevr. Agnès Lemarchand Nomination as a Board Member of Mrs Agnès Lemarchand
	Pour/Voor/For	61.601.977
	Contre/Tegen/Against	274.283
	Abstention/Onthouding/Abstain	147.494
	% Pour/Voor/For	99,56%
6.d.	Total des votes/Totaal aantal stemmen/Total Votes	62.023.754

6.e.	Nomination comme administrateur indépendant de Mme Agnès Lemarchand
	Benoeming als onafhankelijk bestuurder van Mevr. Agnès Lemarchand
	Nomination as a indenpendent Board member of Mrs Agnès Lemarchand
	Pour/Voor/For	61.872.490
	Contre/Tegen/Against	8.420
	Abstention/Onthouding/Abstain	142.844
	% Pour/Voor/For	99,99%
	Total des votes/Totaal aantal stemmen/Total Votes	62.023.754